Michael Jacobsen

Director of Finance/CFO at OMEROS CORPORATION

Net worth: 42 840 $ as of 30/04/2024

65 year

Health Technology

Consumer Services

Michael Jacobsen active positions

Companies	Position	Start	End
OMEROS CORPORATION	Comptroller/Controller/Auditor	01/10/2013	-
	Director of Finance/CFO	01/08/2013	-
	Treasurer	01/10/2013	-

Companies	Position	Start	End
SAREPTA THERAPEUTICS, INC.	Comptroller/Controller/Auditor	08/09/2011	-
	Director of Finance/CFO	09/09/2011	15/11/2011
	Corporate Officer/Principal	08/09/2011	08/09/2011
	Corporate Secretary	07/09/2011	22/04/2013
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Chief Operating Officer	01/04/2007	01/08/2011
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Comptroller/Controller/Auditor	-	-
	Director of Finance/CFO	-	-

Idaho State University

Undergraduate Degree

International

United States

Operational

Comptroller/Controller/Auditor	3
Director of Finance/CFO	3
Corporate Officer/Principal	1

Sectoral

Health Technology	5
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
SAREPTA THERAPEUTICS, INC.	Health Technology
OMEROS CORPORATION	Health Technology

Private companies	2
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Health Technology
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Health Technology

Private companies

Health Technology